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ABSTRACT 
Two novel concepts have been emerged in breast cancer biology: the role of cancer 
stem cells (CSC) in tumor initiation, and the Telomerase role in cell division and 
keeping the CSC immortal, as well as avoiding senesence. CSC are a small 
subpopulation of cells within tumors that initiat the tumor, and renew their self, as 
well as giving rise to a large population of differentiated progeny that constitute the 
bulk of the tumor. Telomerase is the intracellular reverse transecriptase responsible 
for the elongation of chromosomal telomer, which progressively shorten with 
ongoing cell division. 
The objective of this study is to analyse and determine the prevelance, and 
significance of CSC, and Telomerase activity, in primary and metastatic breast 
carcinoma, and correlation inbetween these concepts, then to determine the 
diagnostic importance as well as clinical implication and laboratory feasibility of 
identifying CSC, and telomerase activity in routine clinical practice. 
A total of 167 surgically resected primary invasive breast carcinomas, were 
retrieved from the archive of the Pathology Department , QEH. Specimens were 
obtained from patients who underwent surgery between January 2011 and March 
2013. We analysed the immunohistochemical localization of the breast CSC markers 
CD44 and CD24, by double staining IHC technique, as well as Telomerase activity, 
in formaline fixed parafin embedded tissue of 167 case of invasive breast cancer, 
the result was validated by double staining immunoflourecent, which has done on 
10% of the cases. 
The results from this large clinical study showed that The CSC was 
significantly increased in node-positive tumours (p<0.0001), and n high grade (III) 
tumors (p<0.0001), so CSC are independent, negative prognostic factor, its 
presence indicate poor prognosis, there was considerable high incidence of CSC 
expression in metastatic lymph node lesion compared to primary tumor (p-0.000), 
CSC was more prevalent and in significant number in ductal carcinoma insitu 
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comparing to its invasive counterpart (p- 0.001),. There was no significant 
correlation observed in between Telomerase activity and tumor grade, size, 
lympho-vascular permeation, lymph node status, ER, PR, Her2, and skin or nipple 
involvement, but there was considerable high incidence of Telomerase expression 
in metastatic lymph node lesion. Its wise to conclude that increase number of CSC 
in DOS lesion regarded as an intial step in the stromal invasion and propagation of 
breast cancer, and high prevalence of CSC, promoting tumor invasivness and 
metastasis. There is no association or significant correlation between the existence 
of CSC and detection of Tel om erase activity in tumor cells. 
Finally, we can conclude that the currently used detection methods for CSC are 
not efficient to identify this subtype of tumor cell. The clinical relevance on 
prognosis and therapy response has to be further evaluated in a prospective trial. 
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